Cargando…

Publisher Correction: The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms

Detalles Bibliográficos
Autores principales:	Gao, Xiaobo, Rosales, Alan, Karttunen, Heidi, Bommana, Geetha M., Tandoh, Buadi, Yi, Zhengzi, Habib, Zainab, D’Agati, Vivette, Zhang, Weijia, Ross, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Publisher Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055251/ https://www.ncbi.nlm.nih.gov/pubmed/32132565 http://dx.doi.org/10.1038/s41598-020-60085-4

Ejemplares similares

The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms
por: Gao, Xiaobo, et al.
Publicado: (2019)

Renal HIV Expression Is Unaffected by Serum LPS Levels in an HIV Transgenic Mouse Model of LPS Induced Kidney Injury
por: Leventhal, Jeremy S., et al.
Publicado: (2011)

Structures of Darunavir-Resistant HIV-1 Protease Mutant Reveal Atypical Binding of Darunavir to Wide Open Flaps
por: Zhang, Ying, et al.
Publicado: (2014)

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance
por: Nakashima, Masaaki, et al.
Publicado: (2016)

Evaluation of novel protease inhibitors against darunavir‐resistant variants of HIV type 1
por: Inoue, Mari, et al.
Publicado: (2016)

In Search of C3G Tissue Biomarkers
por: D’Agati, Vivette D., et al.
Publicado: (2019)

Combating HIV resistance – focus on darunavir
por: Tremblay, Cécile L
Publicado: (2008)

Role of darunavir in the management of HIV infection
por: Lascar, R Monica, et al.
Publicado: (2009)

Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir
por: Yu, Yuqi, et al.
Publicado: (2015)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Revealing Origin of Decrease in Potency of Darunavir and Amprenavir against HIV-2 relative to HIV-1 Protease by Molecular Dynamics Simulations
por: Chen, Jianzhong, et al.
Publicado: (2014)

Darunavir-Resistant HIV-1 Protease Constructs Uphold a Conformational Selection Hypothesis for Drug Resistance
por: Liu, Zhanglong, et al.
Publicado: (2020)

Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy
por: Ucciferri, Claudio, et al.
Publicado: (2016)

A Fresh Perspective on Monoclonal Gammopathies of Renal Significance
por: Aucouturier, Pierre, et al.
Publicado: (2021)

De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
por: Bomback, Andrew S., et al.
Publicado: (2021)

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018)

Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines
por: Haynes, Barton F.
Publicado: (2021)

Publisher Correction: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection
por: Colson, Philippe, et al.
Publicado: (2020)

Publisher Correction: Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition
por: Bibas, Michele, et al.
Publicado: (2021)

Profile of darunavir in the management of treatment-experienced HIV patients
por: Wolfe, Cameron, et al.
Publicado: (2009)

Darunavir-based dual therapy in HIV experienced patients
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Publisher Correction: Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Erratum. Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression. Diabetes 2019;68:2301–2314
por: Fan, Ying, et al.
Publicado: (2020)

Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression
por: Fan, Ying, et al.
Publicado: (2019)

Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy
por: Kudose, Satoru, et al.
Publicado: (2021)

Expression of HIV transgene aggravates kidney injury in diabetic mice
por: Mallipattu, Sandeep K, et al.
Publicado: (2013)

Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashokkumar, Manickam, et al.
Publicado: (2020)

Publisher Correction: HIV-1 replication complexes accumulate in nuclear speckles and integrate into speckle-associated genomic domains
por: Francis, Ashwanth C., et al.
Publicado: (2020)

Validation of Simultaneous Quantitative Method of HIV Protease Inhibitors Atazanavir, Darunavir and Ritonavir in Human Plasma by UPLC-MS/MS
por: Mishra, Tulsidas, et al.
Publicado: (2014)

Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study
por: Fenley, Juliana de C., et al.
Publicado: (2022)

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2014)

Publisher Correction: An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes
por: Levinger, Callie, et al.
Publicado: (2021)

The L33F darunavir resistance mutation acts as a molecular anchor reducing the flexibility of the HIV-1 protease 30s and 80s loops
por: Kuiper, Benjamin D., et al.
Publicado: (2015)

Publisher Correction: Neural mechanisms underlying interindividual differences in intergenerational sustainable behaviour
por: Baumgartner, Thomas, et al.
Publicado: (2023)

Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients
por: Dobroszycki, Joanna, et al.
Publicado: (2011)

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data
por: Daskapan, Alper, et al.
Publicado: (2019)

New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
por: Magistroni, Riccardo, et al.
Publicado: (2015)

Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains
por: Papeta, Natalia, et al.
Publicado: (2016)

Collapsing Glomerulopathy Associated With Hydrophilic Polymer Emboli
por: Kudose, Satoru, et al.
Publicado: (2018)

Atypical Infection-Related Glomerulonephritis With “Masked” IgG-Kappa Crystalline Hump-Like Deposits
por: DiFranza, Lanny T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4otman98l3trraafpu0pls9u09